Merck Tbk. vs Nusantara Sawit Sejahtera Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Nusantara Sawit Sejahtera Tbk. trades at Rp790 (market cap 19.04T, 12.69M 24h volume). The key difference: Nusantara Sawit Sejahtera Tbk. is far larger — about 11.2× Merck Tbk.'s market cap, and Nusantara Sawit Sejahtera Tbk. is more actively traded (12.69M versus 37.6K). Which is the better fit depends on your goals.
| MERK | NSSS | |
|---|---|---|
Market Cap | 1.7T | 19.04T |
Volume | 37.6K | 12.69M |
Lot | 376 | 126.87K |
Turnover | 144.47M | 9.75B |
Average Price | 3,842.23 | 768.63 |
Value | 144.47M | 9.75B |
Indicative Equilibrium Price | 3,840 | 790 |
Indicative Equilibrium Volume | 7 | 8.75K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Read more on NSSS →